Aetna, Cigna, UnitedHealthcare to Cover Agendia’s MammaPrint

Agendia announced today that its MammaPrint 70-gene signature breast cancer recurrence risk test has received positive coverage decisions from Aetna, Cigna, and UnitedHealthcare.

According to Agendia, the three insurers cover more than 85 million people in the US and internationally.

Source: https://www.genomeweb.com/molecular-diagnostics/aetna-cigna-unitedhealthcare-cover-agendias-mammaprint